253 related articles for article (PubMed ID: 28422742)
41. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.
Johnson LA; Heemskerk B; Powell DJ; Cohen CJ; Morgan RA; Dudley ME; Robbins PF; Rosenberg SA
J Immunol; 2006 Nov; 177(9):6548-59. PubMed ID: 17056587
[TBL] [Abstract][Full Text] [Related]
42. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
[TBL] [Abstract][Full Text] [Related]
43. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
[TBL] [Abstract][Full Text] [Related]
44. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
45. T Cells Expanded from PD-1
Li T; Zhao L; Yang Y; Wang Y; Zhang Y; Guo J; Chen G; Qin P; Xu B; Ma B; Zhang F; Shang Y; Li Q; Zhang K; Yuan D; Feng C; Ma Y; Liu Z; Tian Z; Li H; Wang S; Gao Q
Cancer Res; 2021 Apr; 81(8):2184-2194. PubMed ID: 33408117
[TBL] [Abstract][Full Text] [Related]
46. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
47. Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.
Rudqvist NP; Pilones KA; Lhuillier C; Wennerberg E; Sidhom JW; Emerson RO; Robins HS; Schneck J; Formenti SC; Demaria S
Cancer Immunol Res; 2018 Feb; 6(2):139-150. PubMed ID: 29180535
[TBL] [Abstract][Full Text] [Related]
48. Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors.
Nanno M; Seki H; Mathioudakis G; Suzuki R; Itoh K; Ioannides CG; Suzuki S; Chen PF; Platsoucas CD
Eur J Immunol; 1992 Mar; 22(3):679-87. PubMed ID: 1312472
[TBL] [Abstract][Full Text] [Related]
49. Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
Zhang AW; McPherson A; Milne K; Kroeger DR; Hamilton PT; Miranda A; Funnell T; Little N; de Souza CPE; Laan S; LeDoux S; Cochrane DR; Lim JLP; Yang W; Roth A; Smith MA; Ho J; Tse K; Zeng T; Shlafman I; Mayo MR; Moore R; Failmezger H; Heindl A; Wang YK; Bashashati A; Grewal DS; Brown SD; Lai D; Wan ANC; Nielsen CB; Huebner C; Tessier-Cloutier B; Anglesio MS; Bouchard-Côté A; Yuan Y; Wasserman WW; Gilks CB; Karnezis AN; Aparicio S; McAlpine JN; Huntsman DG; Holt RA; Nelson BH; Shah SP
Cell; 2018 Jun; 173(7):1755-1769.e22. PubMed ID: 29754820
[TBL] [Abstract][Full Text] [Related]
50. Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma. Relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions.
Puisieux I; Bain C; Merrouche Y; Malacher P; Kourilsky P; Even J; Favrot M
Int J Cancer; 1996 Apr; 66(2):201-8. PubMed ID: 8603812
[TBL] [Abstract][Full Text] [Related]
51. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
[TBL] [Abstract][Full Text] [Related]
52. Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer.
Ham B; Kim SY; Kim YA; Han D; Park T; Cha S; Jung S; Kim JH; Park G; Gong G; Lee HJ; Shin J
Br J Cancer; 2024 May; ():. PubMed ID: 38750113
[TBL] [Abstract][Full Text] [Related]
53. Molecular characterisation of tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Stephens M; Lim K; Stephens P; Thomas DW; Lim SH
Cancer Immunol Immunother; 1998 Mar; 46(1):34-40. PubMed ID: 9520290
[TBL] [Abstract][Full Text] [Related]
54. TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination.
Hsu M; Sedighim S; Wang T; Antonios JP; Everson RG; Tucker AM; Du L; Emerson R; Yusko E; Sanders C; Robins HS; Yong WH; Davidson TB; Li G; Liau LM; Prins RM
Cancer Immunol Res; 2016 May; 4(5):412-418. PubMed ID: 26968205
[TBL] [Abstract][Full Text] [Related]
55. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
56. Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.
Belldegrun A; Tso CL; Kaboo R; Pang S; Pierce W; deKernion JB; Figlin R
J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):149-61. PubMed ID: 8732698
[TBL] [Abstract][Full Text] [Related]
57. Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
Gerlinger M; Quezada SA; Peggs KS; Furness AJ; Fisher R; Marafioti T; Shende VH; McGranahan N; Rowan AJ; Hazell S; Hamm D; Robins HS; Pickering L; Gore M; Nicol DL; Larkin J; Swanton C
J Pathol; 2013 Dec; 231(4):424-32. PubMed ID: 24122851
[TBL] [Abstract][Full Text] [Related]
58. Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics.
Romanens L; Chaskar P; Marcone R; Ryser S; Tille JC; Genolet R; Heimgartner-Hu K; Heimgartner K; Moore JS; Liaudet N; Kaya G; Pittet MJ; Dietrich PY; Delorenzi M; Speiser DE; Harari A; Tsantoulis P; Labidi-Galy SI
Int J Cancer; 2023 Nov; 153(9):1568-1578. PubMed ID: 37306359
[TBL] [Abstract][Full Text] [Related]
59. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
60. Skewed distribution of TCR V alpha 7-bearing T cells within tumor-infiltrating lymphocytes of HLA-A24(9)-positive patients with malignant glioma.
Ebato M; Nitta T; Yagita H; Sato K; Okumura K
Immunol Lett; 1993 Dec; 39(1):53-64. PubMed ID: 8144191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
